Covid: Brazil does not complete vaccination of children and adults – 05/28/2022 – Equilíbrio e Saúde
In the cold of the epidemic, vaccination against Covid-19 in Brazil faces challenges for all ages. The country has difficulty completing the proposed cycles with stable child coverage, low booster in young adults and only 10% of adults with a fourth dose.
This is shown by the analysis carried out Sheet With data from the Ministry of Health and IBGE (Brazilian Institute of Geography and Statistics).
The survey noted that as of the 24th of this month, 4 out of 10 children between the ages of 5 and 11 did not receive the first dose.
After the highest application between January and February, partial coverage decreases and slows down before two-thirds of the first injections (61%) reach children.
Even in the case of Pediatric Pfizer, given the dose-waiting interval of eight weeks, the expectation of returning as a supplement is much lower: only 34% of children have completed the initial vaccination cycle.
Among young people, the barrier is on the third level. Among Brazilians aged 18 to 29, first-cycle coverage দুটি two doses or a single dose of Janssen-reached 81.5%.
However, most of them did not return four months later to receive their first booster, since the Ministry of Health has made recommendations for all adults since November last year.
Applications in this age group have not stopped and have been declining since March. According to the survey, only one-third of young people took the third dose (33%).
The fourth dose has lower adherence in adults. The coverage of this second booster is only 18% of Brazilians aged 80 and over, who have been eligible across the national territory since March.
Dennis Garrett, an epidemiologist and vice president of the Sabine Institute, described the current situation as “regrettable.” He noted that Brazil repeats the same wave as the United States, which is currently experiencing an increase in the number of cases and is being under-reported due to self-examination.
Isabella Ballalai, a pediatrician and vice president of Sbim (Brazilian Society of Immunization), said the situation was “worrying” and that cases had increased in recent weeks.
“A new big wave is not expected, but we may have a variant with a larger vaccine escape,” he warned.
Although the United States has already approved a third dose of the vaccine for people aged 5 to 11, highlighting the pediatrician, Brazil has yet to do its homework and vaccinate children with two doses.
Experts point to the lack of strong vaccination campaigns and noise between the Ministry of Health and the states as possible reasons for the difficulties that the country faces in strengthening the immunization cycle for children and adults.
“Contact with the person is not direct. When they say ‘everyone should be vaccinated’, the 20-year-old doesn’t think it’s him, but only for the elderly,” Ballalai said. “Information is called, but it does not affect the population.”
Since May 18, the Ministry of Health has recommended a fourth dose for all people over the age of 60. Prior to that, many states had already started vaccinating at this age.
The state of Sওo Paulo, for example, launched the March 21 campaign for immunosuppressed adults as well as people 60 years of age or older.
Its lifting Sheet Notably, out of the entire Brazilian population, only 14% of septuagenarians and 6.5% of sexjenarians have already updated their immunizations. Overall, only 1 in 10 adults aged 60 or over received a fourth dose of protection (10.5%).
Ballalai commented that with the epidemic cooling off, most care has been put aside. He believes that the anti-vaccine movement in Brazil made a section of the population believe that the risk of the disease was not so high and that it reduced the demand for immunizers.
An epidemiological analysis published by Fiocruz on Thursday (26) stated that Covid-19 caused 48% of the cases of severe acute respiratory syndrome (SARS) recorded in the last four weeks. The number represents an increase in cases in all regions of the country.
Regarding the lack of adherence to the fourth dose, he blames it on general fatigue and the feeling that the vaccine does not work. “It’s not true. There is a clear difference between those who have been vaccinated at all ages and those who have not.”
Pediatrician Kovid-19 compared the vaccine to the flu and said that very few people know that the first one lasts for 4 to 6 months.
“The flu has a very marked season. It occurs all year round, but is now the highest, so vaccination is needed now. Covid does not have this season, and the maximum can happen at any time,” he said.
The city of Sওo Paulo sent a letter to the Ministry of Health this Wednesday (25) requesting that it approve a fourth dose without infertility for all health professionals and for people aged 50 to 59, as reported by the column panel. The municipal management has requested that the third dose be approved for adolescents between the ages of 12 and 17.
So far, however, no second dose of booster has been predicted to be available to the entire population. Therefore, it is common for those who have already received the third dose six months ago to be less protected against covid.
Its analysis Sheet Currently, about 4.4 million adults (3.4%) between the ages of 18 and 59 are part of this population. By the end of next month, that number should reach 12.4 million (9.6%).
However, experts say there is still no research that supports the need for a fourth dose for the general population.
Julio Croda, an infectologist at Fiocruz, says there is very little data on the added benefits and how long it lasts. “What we do know is that there can be significant benefits to the protection of the elderly. However, in relation to the general population, the data is scarce and contradictory.”
According to infectious disease experts, no country is taking the fourth dose indiscriminately, “even in countries that do not have this access, we need to reduce vaccine inequality.”
Croda added that the core strategy needs to be based on hospitalization and death prevention. Therefore, for the time being, the second booster dose should not be a cause for concern for the majority of the population.
“We will have recitations, yes, occasionally, of cold-related, relaxation of the immune system. However, we need to monitor how much this will affect hospitalization and increased mortality,” the doctor said.
Raquel Stucci, a professor at Unicamp and a consultant to SBI (Brazilian Society of Infectious Diseases), agrees with Croder. “People [imunizadas com as três doses e abaixo de 60 anos] The risk of more serious illness can be calmed down, “he says.
As the virus continues to circulate, he suggests that in case of contact in crowded places, those who come in contact with the elderly the next day and people with comorbidities should wear a mask.